News
24 February 2026
University of Florida Health is restructuring operations by transferring 299 nutrition and food service positions to an external vendor across its four hospitals to optimize efficiency.
Read more...23 February 2026
Merck announces a new organizational structure for its Human Health unit, creating dedicated Oncology and Specialty, Pharma & Infectious Diseases Business Units to drive commercial success in hospital pharmaceutical portfolios.
Read more...20 February 2026
Columbia Asia Hospital Tebrau in Johor Bahru introduces robotic-assisted knee replacement surgery to enhance precision and patient outcomes, alongside plans for NCD focus and facility expansion.
Read more...18 February 2026
Laos Ministry of Health is transforming public hospitals into self-governing entities to improve service standards, resource allocation, and attract more patients.
Read more...18 February 2026
The European Medicines Agency has updated information on critical pharmaceuticals Wezenla ustekinumab and Cejemly sugemalimab, impacting hospital procurement and patient care across Europe.
Read more...18 February 2026
Merck partners with Mayo Clinic to leverage AI, advanced analytics, and multimodal clinical data for accelerating drug discovery and precision medicine initiatives.
Read more...17 February 2026
US medical device firm Edwards Lifesciences has voluntarily terminated its controversial anti-copycat policy, thereby escaping a formal European Commission investigation impacting hospital procurement of cardiovascular devices.
Read more...17 February 2026
Hospitals' mandated price postings under Trump policies are primarily utilized by insurers for contract negotiations rather than patient shopping, amid ongoing compliance issues and regulatory enhancements.
Read more...16 February 2026
Apollo Hospitals Enterprise Limited achieved a 28% year-over-year increase in international patient revenues for Q3FY26, driven by diversification into new markets like Africa, West Asia, and Southeast Asia, offsetting declines from Bangladesh.[3]
Read more...16 February 2026
Picard Medical will unveil first in vitro and in vivo evaluation data for SynCardia’s electromechanical total artificial heart on February 16, 2026, at the EUMS summit in Barcelona, advancing treatments for advanced heart failure.
Read more...